[ET Net News Agency, 27 January 2022] WUXI BIO (02269) fell 4.64% to HK$76.
It hits an intra-day low of HK$75.65, and an intra-day high of HK$79.7. The total shares
traded was 13.27 million, with a value of HK$1.04b. The active buy/sell ratio is 51:49,
with net buying turnover of HK$11.11m. CHINA INT'L CAPITAL CORP HK accounts for greatest
net responsive buying turnover of HK$27.73m, with volume weighted average price of
HK$77.732. CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of
HK$29.29m, with volume weighted average price of HK$77.238. The stock has fallen a
combined 16.8% over the past 5 consecutive trading days.
The Hang Seng Index now fell 561 points, or 2.31% to 23,728; the Hang Seng China
Enterprises Index now fell 223 points, or 2.63% to 8,288; the Hang Seng TECH Index now
fell 228 points, or 4.09% to 5,368; with an overall turnover of HK$57.12b.
The SSE Composite Index now fell 22 points, or 0.64% to 3,433, with an overall turnover
of RMB187.79b.
The SZSE Component Index now fell 182 points, or 1.32% to 13,598, with an overall
turnover of RMB119.95b.
Basic Information
=================
---------------------------------
Nominal 76.000 % Chg -4.64%
High 79.700 Low 75.650
Shares Tr 13.27m Turnover 1.04b
10-D SMA 86.840 %H.V 60.590
20-D SMA 86.188 VWAP 78.647
50-D SMA 92.917 RSI14 34.544
---------------------------------
Status: Active buy/sell ratio is 51:49, with net buying turnover of HK$11.11m, falling a
combined 16.8% over the past 5 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
WUXI BIO (02269) 76.00 -4.64
HUTCHMED (00013) 43.10 -3.69
GENSCRIPT BIO (01548) 24.65 -5.19
ASCLETIS-B (01672) 3.86 -0.52
INNOVENT BIO (01801) 32.55 -12.03
JUNSHI BIO (01877) 44.65 -6.49
JXR (01951) 7.40 -6.80
TIGERMED (03347) 81.05 -5.43
CANSINOBIO-B (06185) 125.60 -6.55
REMEGEN-B (09995) 49.70 -3.59
---------------------------------------------
(ed)